Potapova O, Haghighi A, Bost F, Liu C, Birrer MJ, Gjerset R and Mercola D
ConjuChem's clinical programme did not reach approval
Cell 93 (5), 693704
GLOW contains GHK-Cu, BPC-157, and TB-4
They are also being explored in longevity-focused wellness programs
More strikingly, hesperidin, Isoquercitrin and ugonin J demonstrate additional therapeutic value by improving insulin secretion and glycemic control through their respective dual-pathway modulation of AMPK/SREBP-1C and AMPK/AKT signaling ( 5.9 Polysaccharide Polysaccharide metabolites, serving as natural activators of the AMPK pathway, demonstrate unique multi-target and multi-pathway synergistic regulatory advantages in NAFLD treatment, enabling precise therapeutic intervention